CN Patent

CN105188701A — 3-(咪唑并[1，2-b]哒嗪-3-基乙炔基)-4-甲基-n{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺和它的单盐酸盐的晶形

Assigned to Ariad Pharmaceuticals Inc · Expires 2015-12-23 · 10y expired

What this patent protects

本文公开了3-(咪唑并[1，2-b]哒嗪-3-基乙炔基)-4-甲基-N-{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺游离碱和3-(咪唑并[1，2-b]哒嗪-3-基乙炔基)-4-甲基-N-{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺单盐酸盐的新颖晶形、其药物组合物以及它们的制备和使用方法。

USPTO Abstract

本文公开了3-(咪唑并[1，2-b]哒嗪-3-基乙炔基)-4-甲基-N-{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺游离碱和3-(咪唑并[1，2-b]哒嗪-3-基乙炔基)-4-甲基-N-{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺单盐酸盐的新颖晶形、其药物组合物以及它们的制备和使用方法。

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN105188701A
Jurisdiction: CN
Classification: —
Expires: 2015-12-23
Drug substance claim: No
Drug product claim: No
Assignee: Ariad Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.